Tan, Shirley Siang Ning <br/><br/>
Association of CYP2C19*2 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multiethnic population with drug-eluting stents.  [electronic resource] 

 -  Pharmacogenomics  08 2017 
 - 1225-1239 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Standard No.: </label>10.2217/pgs-2017-0078  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Cardiovascular Diseases--chemically induced<br/>Clopidogrel<br/>Cohort Studies<br/>Cytochrome P-450 CYP2C19--genetics<br/>Drug-Eluting Stents--adverse effects<br/>Drug-Related Side Effects and Adverse Reactions--genetics<br/>Female<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Polymorphism, Genetic--genetics<br/>Risk Factors<br/>Ticlopidine--adverse effects